AAPG ASCENTAGE PHARMA GROUP INTERNATIONAL
Price Chart
Executive Summary
Ascentage Pharma issued a voluntary announcement that its RSU trustee purchased 100,000 existing shares on-market for HK$3,977,000 (approximately HK$39.77/share) to satisfy RSU vesting obligations under the 2022 RSU Scheme. This is a routine trust administration action — the trustee buys shares to deliver against previously granted awards, not an open-market buyback by the company. The purchase represents ~0.027% of outstanding shares, immaterial in size. The filing is purely administrative and has no effect on the company's fundamentals or outlook.
Actionable Insight
No trading action warranted. This is a routine trustee RSU share purchase with zero materiality. The 20-F cross-filing context provides the annual report reference but this 6-K adds no new operational information. Monitor upcoming quarterly disclosures for pipeline updates.
Key Facts
- Trustee purchased 100,000 existing shares on May 27, 2026 at ~HK$39.77 per share for total consideration of HK$3,977,000
- Purchased shares represent ~0.0268% of total issued shares
- Shares are held by trustee under 2022 RSU Scheme to satisfy vesting obligations, not a company buyback
- Trustee now holds 2,265,000 shares total; trustee does not exercise voting rights
- No new RSU grants were made — this is a routine delivery transaction for prior awards
Financial Impact
HK$3,977,000 (~0.027% of outstanding shares) — immaterial
Risk Factors
- No material risks from this filing — administrative only
Market Snapshot
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-061791 |
| Document: ea029232601ex99-1.htm | 0001213900-26-061791 |
| Document: 0001213900-26-061791-index-headers.html | 0001213900-26-061791 |
| Document: 0001213900-26-061791-index.html | 0001213900-26-061791 |
| Document: 0001213900-26-061791.txt | 0001213900-26-061791 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 1, 2026
9d ago
|
6-K
| $19.08 $17.20 | ▼ −9.85% | ▼ −7.10% | $17.07 (−10.53%) |
|
May 28, 2026
12d ago
|
6-K
| $20.01 $17.20 | ▼ −14.04% | ▼ −11.52% | $17.07 (−14.69%) |
|
May 28, 2026
13d ago
|
6-K
| $19.88 $17.87 | ▼ −10.11% | ▼ −10.06% | $17.07 (−14.13%) |
|
May 22, 2026
19d ago
|
6-K
| $21.01 $19.08 | ▼ −9.19% | ▼ −10.86% | $17.07 (−18.75%) |
|
May 22, 2026
19d ago
|
Press Release
| $21.01 $19.08 | ▼ −9.19% | ▼ −10.84% | $17.07 (−18.75%) |
|
May 13, 2026
28d ago
|
6-K
| $21.38 $18.99 | ▼ −11.18% | ▼ −10.02% | $17.07 (−20.16%) |
|
May 12, 2026
29d ago
|
6-K
| $21.16 $18.56 | ▼ −12.29% | ▼ −12.37% | $17.07 (−19.33%) |
|
Apr 22, 2026
7w ago
|
6-K
| $25.13 $22.75 | ▼ −9.47% | ▼ −9.53% | $17.07 (−32.07%) |
|
Apr 22, 2026
7w ago
|
Press Release
| $25.13 $22.75 | ▼ −9.47% | ▼ −9.53% | $17.07 (−32.07%) |
|
Apr 20, 2026
7w ago
|
6-K
| $26.36 $23.37 | ▼ −11.34% | ▼ −12.26% | $17.07 (−35.24%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access